CMS Launches WISeR Model to Cut Overuse in Medicare with AI-Driven Prior Authorization
CMS introduces the WISeR Model pilot program leveraging AI-driven prior authorization to reduce Medicare overuse and fraud in six states from 2026-2031.
CMS introduces the WISeR Model pilot program leveraging AI-driven prior authorization to reduce Medicare overuse and fraud in six states from 2026-2031.
Analysis shows a 25% increase in U.S. private insurer prescription drug denials from 2016-2023, driven by rising drug costs and claim automation. Insights into industry impact and reform efforts.
Alaska's SB 133 mandates 72-hour decision deadlines for health insurance authorizations, increases transparency, and protects patients with chronic conditions, effective 2027.
Alaska's new Senate Bill 133 mandates faster health insurance authorization decisions and increased transparency, enhancing patient access and insurer accountability effective 2027.
Top U.S. insurers including Blue Cross Blue Shield, Humana, Cigna, and UnitedHealthCare pledge to streamline prior authorization by 2027, improving patient access and reducing provider burden.
Major US health insurers commit to streamlining prior authorization to speed medical approvals and reduce patient/provider friction by 2027.
A New Jersey bill aims to expedite access to essential medications for serious mental illnesses by requiring insurers to remove prior authorization and step therapy.
Explore the analysis of prior authorization trends in Medicare Advantage plans from 2009 to 2019, revealing significant insights into healthcare compliance and patient care.